Shenzhen Glory Medical Co Ltd
Shenzhen Glory Medical Co.,Ltd. offers hospital construction and medical system integrated solutions in China and internationally. It operates through Medical Products, Medical Services, and Health Industry segments. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering projects; and medi… Read more
Shenzhen Glory Medical Co Ltd (002551) - Total Assets
Latest total assets as of September 2025: CN¥3.56 Billion CNY
Based on the latest financial reports, Shenzhen Glory Medical Co Ltd (002551) holds total assets worth CN¥3.56 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shenzhen Glory Medical Co Ltd - Total Assets Trend (2007–2024)
This chart illustrates how Shenzhen Glory Medical Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Shenzhen Glory Medical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shenzhen Glory Medical Co Ltd's total assets of CN¥3.56 Billion consist of 48.8% current assets and 51.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 13.0% |
| Accounts Receivable | CN¥655.16 Million | 16.9% |
| Inventory | CN¥258.97 Million | 6.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥280.36 Million | 7.2% |
| Goodwill | CN¥17.44 Million | 0.5% |
Asset Composition Trend (2007–2024)
This chart illustrates how Shenzhen Glory Medical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shenzhen Glory Medical Co Ltd's current assets represent 48.8% of total assets in 2024, a decrease from 61.4% in 2007.
- Cash Position: Cash and equivalents constituted 13.0% of total assets in 2024, down from 21.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 6.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 16.9% of total assets.
Shenzhen Glory Medical Co Ltd Competitors by Total Assets
Key competitors of Shenzhen Glory Medical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
|
China Meheco Co Ltd
SHG:600056
|
China | CN¥36.99 Billion |
Shenzhen Glory Medical Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Shenzhen Glory Medical Co Ltd generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Shenzhen Glory Medical Co Ltd generates $ 0.57 in net profit.
Shenzhen Glory Medical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.25 | 1.88 | 2.51 |
| Quick Ratio | 1.92 | 1.55 | 2.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥900.33 Million | CN¥ 887.57 Million | CN¥ 1.57 Billion |
Shenzhen Glory Medical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shenzhen Glory Medical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.24 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | CN¥3.88 Billion |
| Market Capitalization | $266.49 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shenzhen Glory Medical Co Ltd's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shenzhen Glory Medical Co Ltd's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shenzhen Glory Medical Co Ltd (2007–2024)
The table below shows the annual total assets of Shenzhen Glory Medical Co Ltd from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.88 Billion | -1.37% |
| 2023-12-31 | CN¥3.93 Billion | -7.72% |
| 2022-12-31 | CN¥4.26 Billion | -14.33% |
| 2021-12-31 | CN¥4.97 Billion | -1.74% |
| 2020-12-31 | CN¥5.06 Billion | +7.23% |
| 2019-12-31 | CN¥4.72 Billion | +14.99% |
| 2018-12-31 | CN¥4.10 Billion | -4.78% |
| 2017-12-31 | CN¥4.31 Billion | +6.21% |
| 2016-12-31 | CN¥4.06 Billion | +37.18% |
| 2015-12-31 | CN¥2.96 Billion | +25.54% |
| 2014-12-31 | CN¥2.36 Billion | +16.70% |
| 2013-12-31 | CN¥2.02 Billion | +32.54% |
| 2012-12-31 | CN¥1.52 Billion | +14.68% |
| 2011-12-31 | CN¥1.33 Billion | +171.87% |
| 2010-12-31 | CN¥488.62 Million | +21.23% |
| 2009-12-31 | CN¥403.05 Million | +26.71% |
| 2008-12-31 | CN¥318.10 Million | +50.97% |
| 2007-12-31 | CN¥210.70 Million | -- |